[1]
M. Valentini and H. Zmerly, “Antirheumatic drugs for COVID-19 treatment based on the phases of the disease: Current concept”, J Popl Ther Clin Pharmacol, vol. 27, no. SP1, pp. e14-e25, Jun. 2020, doi: 10.15586/jptcp.v27iSP1.689.